Atlas Trials

A Phase I SAD/MAD and Liver Effect Study of Vitalangio in Venous Thromboembolism Patients .

Clinical trial NCT07618351 · COMPLETED

Trial details

NCT number
NCT07618351
Sponsor
Peking University First Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
ThrombosisCardiovascular Diseases
Start date
2023-06-20
Primary completion
2025-01-23
Enrollment
627

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.